US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist

0.317
-0.002-0.75%

Close Aug 23 16:00 ET

0.345
+0.029+9.10%

Post 20:01 ET

11.56MMarket Cap-458P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-8.42%-5.94M

-28.11%-6.67M

-250.71%-28.71M

-210.02%-8.97M

-366.91%-9.06M

-297.60%-5.48M

-163.49%-5.2M

50.92%-8.19M

19.24%-2.89M

62.16%-1.94M

Net income from continuing operations

-40.64%-12.51M

-9.88%-7.42M

-126.79%-31.48M

-20.40%-5.87M

-192.79%-9.96M

-193.11%-8.9M

-163.07%-6.75M

36.07%-13.88M

-45.97%-4.88M

56.13%-3.4M

Depreciation and amortization

--10K

--9K

--6K

--3K

--0

----

Other non cash items

----

---131K

----

Change In working capital

122.96%5.77M

-108.18%-55K

-123.35%-392K

-446.17%-3.89M

-56.68%240K

457.54%2.59M

245.14%672K

133.19%1.68M

176.00%1.12M

-48.75%554K

-Change in prepaid assets

-122.08%-17K

206.59%279K

-429.07%-849K

-182.42%-150K

-335.68%-867K

-67.37%77K

133.33%91K

-78.87%258K

-63.82%182K

-162.38%-199K

-Change in payables and accrued expense

130.48%5.79M

-157.49%-334K

-67.84%457K

-497.13%-3.74M

47.01%1.11M

1,000.88%2.51M

215.74%581K

383.63%1.42M

147.53%942K

-1.18%753K

Cash from discontinued investing activities

Operating cash flow

-8.42%-5.94M

-28.11%-6.67M

-250.71%-28.71M

-210.02%-8.97M

-366.91%-9.06M

-297.60%-5.48M

-163.49%-5.2M

50.92%-8.19M

19.24%-2.89M

62.16%-1.94M

Investing cash flow

Cash flow from continuing investing activities

-6K

47K

-16K

10.03M

-9.97M

Net PPE purchase and sale

--0

---6K

---88K

---17K

---71K

--0

----

Net investment purchase and sale

----

--135K

--1K

--10.1M

----

--0

Cash from discontinued investing activities

Investing cash flow

--0

---6K

--47K

---16K

--10.03M

---9.97M

--0

Financing cash flow

Cash flow from continuing financing activities

58.33%-10K

-233.33%-8K

240.89%24.68M

-36.36%-75K

233.02%24.78M

78.18%-24K

117.65%6K

16,556.82%7.24M

-41.03%-55K

248,100.00%7.44M

Net common stock issuance

----

242.07%24.73M

-16.36%-64K

----

--7.23M

---55K

----

Proceeds from stock option exercised by employees

--0

33.33%8K

33.33%16K

--1K

--9K

--0

-50.00%6K

-80.65%12K

--0

Net other financing activities

---10K

---16K

---60K

---12K

---24K

----

Cash from discontinued financing activities

Financing cash flow

58.33%-10K

-233.33%-8K

240.89%24.68M

-36.36%-75K

233.02%24.78M

78.18%-24K

117.65%6K

16,556.82%7.24M

-41.03%-55K

248,100.00%7.44M

Net cash flow

Beginning cash position

-15.20%30.44M

-9.67%37.13M

-2.25%41.1M

4.85%46.19M

-46.98%20.44M

-10.32%35.9M

-2.25%41.1M

-28.45%42.04M

-3.54%44.05M

-24.11%38.55M

Current changes in cash

61.55%-5.95M

-28.53%-6.68M

-321.08%-3.98M

-207.33%-9.06M

368.13%25.75M

-939.95%-15.46M

-158.74%-5.2M

94.35%-944K

18.59%-2.95M

207.21%5.5M

End cash Position

19.86%24.5M

-15.20%30.44M

-9.67%37.13M

4.85%46.19M

-46.98%20.44M

-10.32%35.9M

-2.25%41.1M

-3.54%44.05M

Free cash flow

-8.42%-5.94M

-28.23%-6.67M

-251.79%-28.79M

-210.61%-8.99M

-370.57%-9.13M

-297.60%-5.48M

-163.49%-5.2M

50.92%-8.19M

19.24%-2.89M

62.16%-1.94M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-8.42%-5.94M	-28.11%-6.67M	-250.71%-28.71M	-210.02%-8.97M	-366.91%-9.06M	-297.60%-5.48M	-163.49%-5.2M	50.92%-8.19M	19.24%-2.89M	62.16%-1.94M
Net income from continuing operations	-40.64%-12.51M	-9.88%-7.42M	-126.79%-31.48M	-20.40%-5.87M	-192.79%-9.96M	-193.11%-8.9M	-163.07%-6.75M	36.07%-13.88M	-45.97%-4.88M	56.13%-3.4M
Depreciation and amortization	--10K	--9K	--9K	--6K	--3K	--0	--0	--0	--0	----
Other non cash items	----	----	---131K	----	----	----	----	----	----	----
Change In working capital	122.96%5.77M	-108.18%-55K	-123.35%-392K	-446.17%-3.89M	-56.68%240K	457.54%2.59M	245.14%672K	133.19%1.68M	176.00%1.12M	-48.75%554K
-Change in prepaid assets	-122.08%-17K	206.59%279K	-429.07%-849K	-182.42%-150K	-335.68%-867K	-67.37%77K	133.33%91K	-78.87%258K	-63.82%182K	-162.38%-199K
-Change in payables and accrued expense	130.48%5.79M	-157.49%-334K	-67.84%457K	-497.13%-3.74M	47.01%1.11M	1,000.88%2.51M	215.74%581K	383.63%1.42M	147.53%942K	-1.18%753K
Cash from discontinued investing activities
Operating cash flow	-8.42%-5.94M	-28.11%-6.67M	-250.71%-28.71M	-210.02%-8.97M	-366.91%-9.06M	-297.60%-5.48M	-163.49%-5.2M	50.92%-8.19M	19.24%-2.89M	62.16%-1.94M
Investing cash flow
Cash flow from continuing investing activities	0	-6K	47K	-16K	10.03M	-9.97M	0	0	0	0
Net PPE purchase and sale	--0	---6K	---88K	---17K	---71K	--0	--0	--0	--0	----
Net investment purchase and sale	----	----	--135K	--1K	--10.1M	----	----	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	---6K	--47K	---16K	--10.03M	---9.97M	--0	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	58.33%-10K	-233.33%-8K	240.89%24.68M	-36.36%-75K	233.02%24.78M	78.18%-24K	117.65%6K	16,556.82%7.24M	-41.03%-55K	248,100.00%7.44M
Net common stock issuance	----	----	242.07%24.73M	-16.36%-64K	----	----	----	--7.23M	---55K	----
Proceeds from stock option exercised by employees	--0	33.33%8K	33.33%16K	--1K	--9K	--0	-50.00%6K	-80.65%12K	--0	--0
Net other financing activities	---10K	---16K	---60K	---12K	---24K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	58.33%-10K	-233.33%-8K	240.89%24.68M	-36.36%-75K	233.02%24.78M	78.18%-24K	117.65%6K	16,556.82%7.24M	-41.03%-55K	248,100.00%7.44M
Net cash flow
Beginning cash position	-15.20%30.44M	-9.67%37.13M	-2.25%41.1M	4.85%46.19M	-46.98%20.44M	-10.32%35.9M	-2.25%41.1M	-28.45%42.04M	-3.54%44.05M	-24.11%38.55M
Current changes in cash	61.55%-5.95M	-28.53%-6.68M	-321.08%-3.98M	-207.33%-9.06M	368.13%25.75M	-939.95%-15.46M	-158.74%-5.2M	94.35%-944K	18.59%-2.95M	207.21%5.5M
End cash Position	19.86%24.5M	-15.20%30.44M	-9.67%37.13M	-9.67%37.13M	4.85%46.19M	-46.98%20.44M	-10.32%35.9M	-2.25%41.1M	-2.25%41.1M	-3.54%44.05M
Free cash flow	-8.42%-5.94M	-28.23%-6.67M	-251.79%-28.79M	-210.61%-8.99M	-370.57%-9.13M	-297.60%-5.48M	-163.49%-5.2M	50.92%-8.19M	19.24%-2.89M	62.16%-1.94M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall